Defining the invasive biology of clinically relevant LKB1 mutations in lung cancer.

被引：0
|
作者：
Commander, R. [1 ]
Hou, Y. [2 ]
Konen, J. [1 ]
Wilkinson, S. [1 ]
Gilbert-Ross, M. [3 ]
Cooper, L. [2 ]
Marcus, A. I. [3 ]
机构：
[1] Emory Univ, Canc Biol, Atlanta, GA 30322 USA
[2] Emory Univ, Biomed Informat, Atlanta, GA 30322 USA
[3] Emory Univ, Hematol & Med Oncol, Atlanta, GA 30322 USA
来源：
MOLECULAR BIOLOGY OF THE CELL | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
P312
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Loss of Lkb1 provokes highly invasive endometrial adenocarcinomas
    Contreras, Cristina M.
    Gurumurthy, Sushma
    Haynie, J. Marshall
    Shirley, Lane J.
    Akbay, Esra A.
    Wingo, Shana N.
    Schorge, John O.
    Broaddus, Russell R.
    Wong, Kwok-Kin
    Bardeesy, Nabeel
    Castrillon, Diego H.
    CANCER RESEARCH, 2008, 68 (03) : 759 - 766
  • [42] The role of Lkb1 in pancreatic development and cancer
    Bardeesy, N
    Lopez, L
    Depinho, RA
    JOURNAL OF INTERNAL MEDICINE, 2004, 255 (06) : 704 - 705
  • [43] LKB1 mutation in large cell carcinoma of the lung
    Zhong, Diansheng
    Guo, Lizheng
    de Aguirre, Itziar
    Liu, Xiuju
    Lamb, Neil
    Sun, Shi-Yong
    Gal, Anthony A.
    Vertino, Paula M.
    Zhou, Wei
    LUNG CANCER, 2006, 53 (03) : 285 - 294
  • [44] LKB1 Mutations Frequently Detected in Mucinous Bronchioloalveolar Carcinoma
    Osoegawa, Atsushi
    Kometani, Takuro
    Nosaki, Kaname
    Ondo, Kaoru
    Hamatake, Motoharu
    Hirai, Fumihiko
    Seto, Takashi
    Sugio, Kenji
    Ichinose, Yukito
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (09) : 1132 - 1137
  • [45] Modulating tumor immune microenvironment by the STK11/LKB1 signaling in breast cancer.
    Hsu, Hui-Ping
    Wang, Chih-Yang
    Kuo, Yao-Lung
    Lee, Kuo-Ting
    Chen, Pai-Sheng
    Cheung, Chun Hei Antonio
    Shen, Che-Hung
    Chang, Chih-Peng
    Chen, Yi-Ling
    Lai, Ming-Derg
    Shen, Meng-Ru
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [46] The role of STK11/LKB1 in cancer biology: implications for ovarian tumorigenesis and progression
    Kang, Jian
    Gallucci, Stefano
    Pan, Junqi
    Oakhill, Jonathan S.
    Sanij, Elaine
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 12
  • [47] The hexosamine biosynthesis pathway is a targetable liability in KRAS/LKB1 mutant lung cancer
    Jiyeon Kim
    Hyun Min Lee
    Feng Cai
    Bookyung Ko
    Chendong Yang
    Elizabeth L. Lieu
    Nefertiti Muhammad
    Shawn Rhyne
    Kailong Li
    Mohamed Haloul
    Wen Gu
    Brandon Faubert
    Akash K. Kaushik
    Ling Cai
    Sahba Kasiri
    Ummay Marriam
    Kien Nham
    Luc Girard
    Hui Wang
    Xiankai Sun
    James Kim
    John D. Minna
    Keziban Unsal-Kacmaz
    Ralph J. DeBerardinis
    Nature Metabolism, 2020, 2 : 1401 - 1412
  • [48] Immunohistochemical Loss of LKB1 Is a Biomarker for More Aggressive Biology in KRAS-Mutant Lung Adenocarcinoma
    Calles, Antonio
    Sholl, Lynette M.
    Rodig, Scott J.
    Pelton, Ashley K.
    Hornick, Jason L.
    Butaney, Mohit
    Lydon, Christine
    Dahlberg, Suzanne E.
    Oxnard, Geoffrey R.
    Jackman, David M.
    Jaenne, Pasi A.
    CLINICAL CANCER RESEARCH, 2015, 21 (12) : 2851 - 2860
  • [49] Suppression of STING Associated with LKB1 Loss in KRAS-Driven Lung Cancer
    Kitapma, Shunsuke
    Ivanova, Elena
    Guo, Sujuan
    Yoshida, Ryohei
    Campisi, Marco
    Sundararaman, Shrirarn K.
    Tange, Shoichiro
    Mitsuishi, Yoichiro
    Thai, Tran C.
    Masudaa, Sayuri
    Piel, Brandon P.
    Sholl, Lynette M.
    Kirschmeier, Paul T.
    Paweletz, Cloud P.
    Watanabe, Hideo
    Yajima, Mamiko
    Barbie, David A.
    CANCER DISCOVERY, 2019, 9 (01) : 34 - 45
  • [50] PREDICTIVE VALUE OF LKB1 IN PATIENTS WITH RESECTED NON SMALL CELL LUNG CANCER
    Fabre, E.
    Pecuchet, N.
    Laurent-Puig, P.
    Pallier, K.
    Le Pimpec-Barthes, F.
    Riquet, M.
    Cazes, A.
    Blons, H.
    ANNALS OF ONCOLOGY, 2012, 23 : 77 - 77
12345